Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stands against the other stocks.

Micro- and small-cap companies dominated the stock market last week, clocking in impressive gains on the back of a flurry of catalysts that boosted investing appetite.

We named last week’s top 10 performers that outperformed the Russell 2000 index, which dropped by 4.04 percent week-on-week. Among them, one firm particularly stood out with its outstanding 317-percent jump, thanks to a $1-billion deal that could fuel its growth prospects.

To come up with the list, we considered the stocks with the highest week-on-week change, comparing their share prices on March 7 and February 28.

We classified micro-cap companies as those with a market capitalization below $300 million and small-cap firms as those with a market capitalization below $2 billion.

Jim Cramer Sees Upside in Ulta Beauty (ULTA) Following CEO Appointment

A photograph of a customer testing out different products in the skincare aisle at a store.

Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH)

Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) surged by 46.7 percent last week to end at $7.69 on Friday versus the $5.24 closing week-on-week despite the lack of fresh catalysts to boost investing appetite.

Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH), a China-based company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, is also a newly listed firm on the US stock exchange, having debuted on December 27, 2024.

From its initial public offering price of $4 apiece, Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH)’s latest stock price already marked a 92.25-percent jump, signaling investor optimism.

Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) was able to raise $4.8 million from its IPO, with net proceeds intended to be used for expanding the scale of directly-owned stores in the PRC, purchasing existing product patents to develop proprietary products, and acquiring ingredient suppliers to reduce production costs over the long term.


READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.